Market Tracker

08/26 5:16pm ET

Clovis Oncology Inc (NASDAQ:CLVS)

23.15
Delayed Data
As of Aug 26
 +0.42 / +1.85%
Today’s Change
11.57
Today|||52-Week Range
116.75
-33.86%
Year-to-Date

Today’s Trading

Previous close22.73
Today’s open23.01
Day’s range22.56 - 24.45
Volume3,441,189
Average volume (3 months)1,384,531
Market cap$891.3M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-107.42%
Earnings growth (this year)+4.72%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.95

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc+0.61+2.92%
AMPHAmphastar Pharmaceut...+0.22+1.14%
ADROAduro Biotech Inc-0.38-2.76%
CLLSCellectis SA+0.10+0.38%
Data as of 4:14pm ET, 08/26/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$2.01
Annual revenue (last year)$0.00
Annual profit (last year)-$352.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
VP, Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts